Document:

QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.58    
    

 
 

AGILENT TECHNOLOGIES, INC.
  1999 NON-EMPLOYEE DIRECTOR STOCK PLAN
  
    (Amended and Restated Effective November 1, 2005)    

PART
I.    PLAN ADMINISTRATION AND ELIGIBILITY 

        1.     Purpose.    The
purpose of this 1999 Non-Employee Director Stock Plan (the "Plan") of Agilent Technologies, Inc.
(the "Company") is to encourage ownership in the Company by outside directors of the Company (each, a "Non-Employee Director," or collectively, the "Non-Employee Directors")
whose continued services are considered essential to the Company's continued progress and thus to provide them with a further incentive to remain as directors of the Company. 

        2.     Administration.    The
Board of Directors (the "Board") of the Company or any committee (the "Committee") of the Board that will
satisfy Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and any regulations promulgated thereunder, as from time to time in effect, including any
successor rule ("Rule 16b-3"), shall supervise and administer the Plan. The Committee shall consist solely of two or more non-employee directors of the Company, who
shall be appointed by the Board. A member of the Board shall be deemed to be a "non-employee director" only if he or she satisfies such requirements as the Securities and Exchange
Commission may establish for non-employee directors under Rule 16b-3. Members of the Board receive no additional compensation for their services in connection with the
administration of the Plan. 

        The
Board or the Committee may adopt such rules or guidelines, as it deems appropriate to implement the Plan. The Board or the Committee shall determine all questions of interpretation
of the Plan or of any shares issued under it and such determination shall be final and binding upon all persons having an interest in the Plan. Any or all powers and discretion vested in the Board or
the Committee under this Plan may be exercised by any subcommittee so authorized by the Board or the Committee and satisfying the requirements of Rule 16b-3. 

        3.     Participation
in the Plan.    Each member of the Board who is not an employee of the Company or any of its subsidiaries or
affiliates shall be eligible to receive payment for his or her Annual Retainer (as defined in Section 12 below) under the Plan. 

        4.     Stock
Subject to the Plan.    The maximum number of shares of the Company's $0.01 par value Common Stock ("Common Stock") which may
be issued under the Plan shall be One Million (1,000,000). The limitation on the number of shares that may be issued under the Plan shall be subject to adjustment as provided in Section 10 of
the Plan. 

        If
any outstanding option or grant of Common Stock under the Plan for any reason expires or is terminated without having been vested or exercised in full, the shares allocable to the
unexercised portion of such option or the grant of Common Stock shall again become available for grant pursuant to the Plan. 

PART
II.    TERMS OF THE PLAN 

        5.     Term
of the Plan.    The Plan shall become effective upon the earlier to occur of its adoption by the Board or its approval by the
shareholders of the Company as described in Section 15 of the Plan. It shall continue in effect for a term of ten (10) years unless sooner terminated under Section 11 of the Plan. 

        6.     Time
for Granting Options.    No options shall be granted, and no Deferred Share grant (as provided for in Section 7(c) and
7(d) below) shall be made, after the date on which this Plan terminates. The applicable terms of this Plan, and any terms and conditions applicable to the options granted or shares issued prior to
such date, shall survive the termination of the Plan and continue to apply to such options and shares. 

        7.     Terms
and Conditions. 

        (a)   Compensation.    Except
for the Non-Executive Chairman, each Non-Employee Director's Annual Retainer shall
consist of an option to purchase shares of Common Stock (an "Option Payment") in an amount equivalent to sixty-five
thousand dollars ($65,000.00) and sixty-five thousand dollars ($65,000.00) payable in cash in four (4) quarterly installments (the "Cash Payment"). 

        In
addition, Non-Employee Directors who serve as the chairperson of a Board committee shall be entitled to a "Committee Chair Premium". Specifically, the chairpersons of both
the Compensation Committee and the Audit and Finance Committee of the Board, provided they are not the Non-Executive Chairman, shall, on an annual basis, receive an additional ten thousand
dollars ($10,000.00) in cash and the chairperson of all other Board committees, provided that they are not the Non-Executive Chairman, shall, on an annual basis, receive an additional five
thousand dollars ($5000.00) in cash. 

        The
Non-Executive Chairman shall receive an Annual Retainer that shall consist of an option to purchase shares of Common Stock (an "Option Payment") in an amount equivalent
to sixty-five thousand dollars ($65,000.00) and two hundred sixty thousand dollars ($260,000.00) in cash. The Non-Executive Chairman shall not be eligible to receive any
Committee Chair Premiums. 

        (b)   Option
Payment.    Each option granted under this Plan shall be a non-statutory option and shall be evidenced by a
written agreement in such form as the Board or Committee shall from time to time approve, which Agreements shall comply with and be subject to the following terms and conditions and such additional
terms and conditions as may be determined by the Board or Committee: 

        (i)    Date
of Payment.    For each Plan Year, an option constituting the Option Payment shall be granted in the prior Plan Year
automatically on the date that the Company makes its regular annual grant of equity awards to employees who are officers of the Company within the meaning of Section 16 of the Exchange Act;
provided, that in the case of a Non-Employee Director who subsequently ceases to be a member of the Board of Directors for any reason on or prior a Vesting Date as provided in
Section 7(v) below, except as provided in Section 7(vi) below, such option shall be automatically cancelled to the extent not yet exercisable on the date of such cessation,
and the shares that were subject to the unexercisable portion thereof shall become available for future grant under the Plan (unless the Plan has terminated). 

        (ii)   Number
of Shares Subject to Option.    The number of shares to be subject to any option granted pursuant to the Plan shall be an
amount necessary to make such option equal in value, using an option valuation model, as determined by the Board or Committee, to sixty-five thousand dollars ($65,000). The value of the
option will be calculated by assuming that the value of an option to purchase one share of Common Stock equals the product of (i) the Multiplier, as defined below, and
(ii) the average Fair Market Value of a share of Common Stock for the period described below ending on the date of grant. 

        The
number of shares represented by an option granted pursuant to the Plan shall be determined by multiplying the number of shares determined in Section 7(b)(ii) above by a
multiplier determined using an option valuation method (the "Multiplier"). The Board or the Committee shall determine the Multiplier prior to the option grant made with respect to any succeeding Plan
Year. The number of shares to be subject to the option shall be equal to the number of whole shares determined as follows: 

	$65,000.00
	 	= Number of shares
	The average Fair Market Value for the 20 trading days ending prior to the grant date.	 	x Multiplier	 	 

        (iii)  Price
of Options.    The exercise price of the option will be the Fair Market Value of the Common Stock on the date of grant. 

        (iv)  Exercise
of Options.    Options may be exercised only by written notice to the Company at its head office accompanied by payment
in cash of the full consideration for the shares as to which they are exercised. 

        (v)   Vesting
and Term of Option.    Except as provided in Section 7(vi) below, the option will vest and become
exercisable in four (4) twenty-five percent (25%) increments (the date as of which an increment vests a "Vesting Date"). The first Vesting Date shall be the date of the annual
shareholders meeting next following the grant date, and an increment shall vest as of the first Vesting Date only with respect to 

Non-Employee
Directors who will continue as members of the Board following the shareholders meeting. The second, third and fourth Vesting Dates shall be the dates six months, nine months
and one year, respectively, following the grant date. An increment shall vest and become exercisable on the second, third or fourth Vesting Date only to the extent the Non-Employee
Director continues as a member of the Board on the Vesting Date. No option shall be exercisable after the expiration of ten (10) years from the date upon which such option is granted. 

        (vi)  Exercise
by Representative Following Death of Director.    A Non-Employee Director, by written notice to the Company,
may designate one or more persons (and from time to time change such designation) including his or her legal representative, who, by reason of his or her death, shall acquire the right to exercise all
or a portion of the option. If the person or persons so designated wish to exercise any portion of the option, they must do so within the term of the option as provided in Section 7(b)(v). Any
exercise by a representative shall be subject to the provisions of this Plan. 

        (vii) Options
Nontransferable.    Unless determined otherwise by the Board or the Committee, each option granted under the Plan by its
terms shall not be transferable by the optionee otherwise than by will, or by the laws of descent and distribution, and shall be exercised during the lifetime of the optionee only by him. No option or
interest therein may be transferred, assigned, pledged or hypothecated by the optionee during his or her lifetime, whether by operation of law or otherwise, or be made subject to execution, attachment
or similar process. 

        (c)   Annual
Deferred Share Credit.    For each Plan Year, each Non-Employee Director shall be credited under the Agilent
Technologies, Inc. 2005 Non-Employee Director Deferred Compensation Plan (the "Deferred Compensation Plan"), as of the later of March 1st of each Plan Year (or
if March 1 is not a business day the next succeeding business day) or the first business day following the annual shareholders meeting, with a deemed investment in shares of Common Stock
("Shares"), as that term is defined under the Deferred Compensation Plan), with a Fair Market Value of sixty-five thousand dollars ($65,000), determined as provided below. The Shares shall
vest in four (4) twenty-five percent (25%) increments each three (3) months from the date of credit, provided the Non-Employee Director continues in Board service
on the vesting date. Shares credited under this Section 7(c) shall be issued from this Plan. 

        The
number of Shares subject to an Annual Deferred Share Credit shall be equal to the number of whole Shares determined as follows: 

	$65,000.00
	 	= Number of shares
	The average Fair Market Value for the 20 trading days ending prior to the grant date	 	 	 	 

        (d)   Deferred
Share Credit for New Directors.    Effective as of November 1, 2005, each newly appointed Non-Employee
Director shall be credited under the Deferred Compensation Plan, as of the date service commences as a Non-Employee Director, with Shares (as that term is defined under the Deferred
Compensation Plan) with a Fair Market Value of one hundred thirty thousand dollars ($130,000.00), determined as provided below. The Shares shall vest in four (4) twenty-five percent
(25%) increments each three (3) months from the date of credit, provided the Non-Employee Director continues in Board service on the vesting date. Shares credited under this
Section 7(d) shall be issued from this Plan. 

        The
number of Shares subject to a grant under this Section 7(d) shall be equal to the number of whole shares determined as follows: 

	$130,000.00
	 	= Number of shares
	The average Fair Market Value for the 20 trading days ending prior to the grant date	 	 	 	 

        (e)   Cash
Payment and Committee Chair Premiums.    Unless a Non-Employee Director has properly elected to defer all or part
of the cash component of his or her Annual Retainer and Committee Chair Premium under a deferred compensation plan sponsored by the Company, all Cash Payments shall be made in four
(4) quarterly installments (provided the Non-Employee Director continues as a Board member on the installment date). Committee Chair Premiums shall be made in a lump sum payment as
soon as practicable following the later of March 1 of each Plan Year (or, if March 1 is not a business day, on the next succeeding business day) or the first business day following the
annual shareholders meeting. 

        (f)    Special
Compensation.    The Board or the Committee may, from time to time, deem it appropriate and may provide certain
Non-Employee Directors with additional compensation ("Special Compensation") under this Plan. Such Special Compensation shall be in the form of a grant of Common Stock or stock options
subject to terms, conditions and restrictions established by the Board or Committee at the time of the grant. 

        (g)   Form
of Issuance of Shares.    Any shares issued under the Plan shall be in either book entry form or in certificate form pursuant
to the instructions given by the Non-Employee Director to the Company's transfer agent. 

        (h)   Transferability.    In
the event of a Non-Employee Director's death, all of such person's rights to receive any
accrued but unpaid Option Payment and/or Special Compensation will transfer to the maximum extent permitted by law to such person's beneficiary. Each Non-Employee Director may name, from
time to time, any beneficiary or beneficiaries (which may be named contingently or successively) as his or her beneficiary for purposes of this Plan. Each designation shall be on a form prescribed by
the Committee, will be effective only when delivered to the Company and when 

effective
will revoke all prior designations by the Non-Employee Director. If a Non-Employee Director dies with no such beneficiary designation in effect, such person's
beneficiary shall be his or her estate and such person's payments will be transferable by will or pursuant to laws of descent and distribution applicable to such person. 

PART
III.    GENERAL PROVISIONS 

        8.     Assignments.    The
rights and benefits under this Plan may not be assigned except for the designation of a beneficiary as provided
in Section 7. 

        9.     Limitation
of Rights. 

        (a)   No
Right to Continue as a Director.    Neither the Plan, nor the issuance of shares of Common Stock, nor the grant of special
Compensation, nor any other action taken pursuant to the Plan, shall constitute or be evidence of any agreement or understanding, express or implied, that the Company will retain a director for any
period of time, or at any particular rate of compensation. 

        (b)   No
Stockholders' Rights for Options.    An optionee shall have no rights as a stockholder with respect to the shares covered by
his or her options until the date of the issuance to him of a stock certificate therefor or the making of a book entry with the Company's transfer agent, and no adjustment will be made for dividends
or other rights for which the record date is prior to the date such certificate is issued. 

        10.   Adjustments
in Present Stock.    In the event of any merger, consolidation, reorganization, recapitalization, stock dividend,
stock split, or other change in the corporate structure or capitalization affecting the Company's present Common Stock, at the time of such event the Board or the Committee shall make appropriate
adjustments to the number (including the aggregate numbers specified in Section 4) and kind of shares to be issued under the Plan and the price of any Stock Option. 

        11.   Amendment
and Termination of the Plan. 

        (a)   Amendment
and Termination.    The Board may at any time amend, alter, suspend, or discontinue the Plan, but no amendment,
alteration, suspension, or discontinuation shall be made which would impair the awards granted to any Non-Employee Director theretofore made, without his or her consent. In addition, to
the extent necessary and desirable to comply with any applicable law, regulation or stock exchange rule, the Company shall obtain shareholder approval of any Plan amendment in such a manner and to
such a degree as required. 

        (b)   Effect
of Amendment or Termination.    Any such amendment or termination of the Plan shall not affect any Stock Option already
granted and such Stock Options shall remain in full force and effect as if this Plan had not been amended or terminated. 

        12.   Definitions.

        "Annual Retainer" shall mean the amount to which a Non-Employee Director will be entitled to receive for serving as a director
in a relevant Plan Year, but shall not include reimbursement for expenses, fees associated with service on any committee of the Board or fees with respect to any other services to be provided to the
Company. 

        "Fair Market Value" shall mean, as of any date, the average of the highest and lowest quoted sales prices for the Common Stock as of such
date (or if no sales were reported on such date, the average on the last preceding day a sale was made) as quoted on the stock exchange or national market system on which the Common Stock is listed,
with the highest trading volume, as reported in such source as the Company shall determine. 

        "Non-Executive Chairman" shall mean the Non-Employee Director who is appointed to serve as the Chairman of the
Board. 

        "Plan Year" shall mean the year beginning March 1 and ending February 28, or February 29, as the case may be. 

        13.   Notice.    Any
written notice to the Company required by any of the provisions of this Plan shall be addressed to the Secretary of
the Company and shall become effective when it is received. 

        14.   Governing
Law.    This Plan and all determinations made and actions taken pursuant hereto shall be governed by the law of the
State of Delaware and construed accordingly. 

        15.   Shareholder
Approval.    The Plan shall be subject to approval by the shareholders of the Company within twelve (12) months
after the date the Plan is adopted. Such shareholder approval shall be obtained in the degree and manner required under applicable state and federal law and any stock exchange rules. 

        16.   Annual
Maximum Shares.    Subject to adjustments as provided in Section 10 of the Plan, the maximum number of shares that
can be granted to each Non-Employee Director under the Plan is 150,000 shares per year. 

QuickLinks

Exhibit 10.58

AGILENT TECHNOLOGIES, INC. 1999 NON-EMPLOYEE DIRECTOR STOCK PLAN (Amended and Restated Effective November 1, 2005)QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.59    
    

 
 

AGILENT TECHNOLOGIES, INC.
  2005 DEFERRED COMPENSATION PLAN FOR NON-EMPLOYEE DIRECTORS
  
    (Amended and Restated Effective as of November 1, 2005)    
    

Section 1.    Establishment and Purpose of Plan.

        The
Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors (the "Plan") was adopted and established effective as of November 1, 2004. The Plan continues
the program of deferred compensation embodied in the document for the Agilent Technologies, Inc. Deferred Compensation Plan for Non-Employee Directors (the "Prior Plan Document") in a manner designed
to comply with the requirements of the American Jobs Creation Act of 2004. The rules of this Plan document, rather than those of the Prior Plan Document, will govern new deferrals. The Plan was
amended and restated effective as of November 1, 2005. 

        The
Plan is intended to be an unfunded and unsecured deferred compensation arrangement between the Director and Agilent, in which the Director agrees to give up a percentage of the
Director's cash portion of his or her annual retainer and/or committee fees in exchange for Agilent's unfunded and unsecured promise to make a payment at a future date, as specified in
Section 6. Agilent retains the right, as provided in Section 13, to amend or terminate the Plan at any time. Certain capitalized words used in the text of the Plan are defined in Section 21 in
alphabetical order. 

Section 2.    Participation in the Plan.

        All
Directors are eligible to defer some or all of the cash portion of their annual retainer and committee fees. 

Section 3.    Timing and Amounts of Deferred Compensation.

        3.1   Annual
Retainer/Committee Fees Deferral. 

        (a)   Timing
of Annual Retainer/Committee Fees Deferral.    With respect to each Plan Year, a Director must make an election, if any, to
defer a percentage of the cash portion of his or her annual retainer payment and/or committee fees otherwise becoming payable during such Plan Year on or before December 31, or such earlier date
established by the Committee, of the preceding the Plan Year. All such elections shall be made in accordance with any procedures established by the Committee. The term "Plan Year" shall mean the
one-year period beginning on March 1 and ending on the next subsequent February 28, or February 29, as the case may be. A newly elected or appointed Director must make an initial deferral election, if
any, within 30 days of becoming a Director. 

 

        (b)   Amount
of Annual Retainer/Committee Fees Deferral.    A Director may defer with respect to a Plan Year any portion, up to 100%, of
any annual cash retainer payment and/or committee fees to which he or she may become entitled during such Plan Year, so long as the deferral amount is expressed in terms of a dollar amount or a whole
percentage point. Once an election is made by a Director to defer any portion or all of an annual cash retainer payment and/or committee fees, the appropriate dollar amount will be withheld from the
annual cash retainer or committee fee, as the case may be, at the time that this amount would have otherwise been paid. 

        3.2   Suspension.    A
Director's participation in the Plan shall be suspended for any period during which he or she ceases to qualify
as a Director, but is then an employee of Agilent or one of its affiliates. However, during such suspension period, the Director's Deferral Account shall continue to share in the Plan. 

        3.3   Committee
Discretion.    Notwithstanding anything in this Section 3 to the contrary, the Committee shall have the discretion to
modify the availability and timing of a valid deferral election under this Section 3, in any manner it deems appropriate; provided, however, that any alteration must comply with Section 409A of the
Code, and any alteration with respect to a Covered Officer must be consistent with the requirements for deductibility of compensation under Section 162(m) of the Code. 

        3.4   Deferred
Share Credits.    Effective November 1, 2005, a Director's Deferral Account shall automatically be credited with a deemed
investment in Shares ("Deferred Share Credits") as provided under the Agilent Technologies, Inc. 1999 Non-Employee Director Stock Plan (the "Director Stock Plan"). The number of Shares credited under
this Section 3.4 shall be determined under the Director Stock Plan. The right to Shares credited under this Section 3.4 shall vest and become nonforfeitable as provided in the Director Stock Plan. 

Section 4.    Deferral Accounts.

        4.1   Crediting
in General.    Amounts deferred pursuant to Section 3 above shall be credited to a Deferral Account in the name of the
Director. Deferred Amounts arising from deferrals of annual cash retainer payments or committee fees shall be credited to a Deferral Account as soon as practicable after the time that such deferred
annual retainer or committee fees would otherwise have been paid. Deferred Amounts in the form of Deferred Share Credits shall be credited as provided in the Director Stock Plan. The Director's rights
in the Deferral Account shall be no greater than the rights of an unsecured general creditor of Agilent. Deferred Amounts invested hereunder shall for all purposes be part of the general funds of
Agilent. Any payout to a Director of amounts credited to a Director's Deferral Account is not due, nor is such amount ascertainable, until the Payout Commencement Date. 

Section 5.    Investment of Deferred Amounts; Dividends

        5.1   Investment
of Deferred Amounts.    Amounts deferred pursuant to Section 3 above shall be deemed to be invested wholly in Shares. 

        5.2   Determination
of Number of Shares.    The number of Shares in which the Deferred Amount credited to a Director's Deferral Account
on a Payment Date (as defined below) shall be 

2

 

determined
by dividing the dollar value of such Deferred Amount by the Fair Market Value of a share of the common stock of Agilent Technologies, Inc. on the Payment Date. For purposes of this Plan,
the term "Payment Date" shall mean the payment date as specified and established by the Committee under the Director Stock Plan. 

        5.3   Fair
Market Value.    For purposes of this Plan, the term "Fair Market Value" shall mean the average of the high and low trading
prices of a share of the common stock of Agilent Technologies, Inc. on the applicable date as reported in The Wall Street Journal or such other source as the Company deems reliable. 

        5.4   Timing
of Investment.    With respect to all Plan Years, investment of the Directors' Deferral Amounts in the Shares under the
Agilent Stock Fund will be made automatically on the Payment Date. 

        5.5   Dividends.    Shares
credited to a Director's Deferral Account will be credited with dividend equivalents until such amounts are
paid out to the Director under this Plan as set forth in Section 6. All dividend equivalents attributable to the Deferral Account shall be added to the liability of and retained therein by Agilent.
Any such addition to the liability shall be appropriately reflected on the books and records of Agilent and identified as an addition to the total sum owing the Director. All such dividend equivalents
shall be automatically reinvested in additional Shares under the Plan. Dividend equivalents attributable to unvested Shares shall be unvested. 

Section 6.    Payout to Directors.

        6.1   Termination.    If
a Director's Deferral Account balance is equal to or greater than $25,000 on the Termination Date, the form and
commencement of such benefit may be made in accordance with the Director's election at the time of deferral and this Section 6.1. If a Director's Deferral Account balance is less than $25,000 on the
Termination Date, the form of such benefit shall be a single lump sum payout in the first pay period in January of the year following the Termination Year. 

        (a)    Form
of Payout.    A Director making a valid election under this Section 6.1 may elect to receive either (i) a single lump sum
payout in the first pay period in January of the year following the Termination Year, or (ii) a payout in annual installments over a five (5) to fifteen (15) year period beginning in the first pay
period in January following the Termination Year. Payment of the Director's Deferral Account shall be made in the form of Shares. 

        (b)    Commencement
of Payout.    A Director making a valid election under this Section 6.1 may elect to further defer the Payout
Commencement Date, under either the single lump sum or the annual installment election addressed in Section 6.1(a), by an additional one (1), two (2) or three (3) years. 

        (c)    Dividend
Equivalents on Deferral Accounts.    Whatever the form of payout under Section 6, and whatever the timing of the Payout
Commencement Date, the Deferral Account of a Director shall continue to be credited with dividend equivalents until all amounts in such an account are paid out to the Director. 

3

 

        6.2   Default
Form and Commencement of Payout.    If a valid election under Section 6.1 is not made, and the Director's Deferral Account
balance is equal to or greater than $25,000 on the Termination Date, then the Director shall receive his or her payout in annual installments over the fifteen (15) year period beginning in the first
pay period in January following the Termination Year. If, however, such Deferral Account balance is less than $25,000 on the Termination Date, then the Director shall receive a single lump sum payout
in the first pay period in January following the Termination Year. 

        6.3   Death
of Director.    If a Director dies and an election was made under Section 6.1, the Beneficiary will be paid according to the
election even though the election was not made twelve (12) months or more prior to the Director's death. If the Director dies and no valid election was made, and the Director's Deferral Account
balance is equal to or greater than $25,000 on the date of death, then the Beneficiary will receive the payout in annual installments over the fifteen (15) year period beginning in the first pay
period in January in the calendar year following the year of the Director's death. If, however, such Deferral Account balance is less than $25,000 on the date of death, then the Beneficiary shall
receive a single lump sum in the first pay period in January of the year following the year of death. 

        6.4   Committee
Discretion.    Notwithstanding anything in this Section 6 to the contrary, the Committee shall have the discretion to
modify the availability and timing of a valid election, and the timing, form and amount of any payout, in any manner it deems appropriate (except that a Director who is then serving as a member of the
Committee may not participate in any such decision that affects his or her Deferral Account); provided, however, that any alteration must comply with Section 409A of the Code, and any alteration with
respect to a Covered Officer must be consistent with the requirements for deductibility of compensation under Section 162(m) of the Code. 

        6.5   Specified
Employees.    Notwithstanding any other Plan provision, no payment to a "specified employee" (as defined in Section 409A
of the Code) shall commence earlier than six (6) months after the date of such individual's Termination Date (except in the case of a termination by death). The commencement of a validly elected
payment shall be delayed to the day that is six (6) months after such separation. 

Section 7.    Hardship Provision for Unforeseeable Emergencies.

        Neither
the Director nor his or her Beneficiary is eligible to withdraw amounts credited to a Deferral Account prior to the time specified in Section 6. However, such credited amounts
may be subject to early withdrawal if (1) an unforeseeable emergency occurs that is caused by a sudden and unexpected illness or accident of the Director or of a dependent (as defined in Section
152(a) of the Code) of the
Director, loss of the Director's property due to casualty, or other similar extraordinary and unforeseeable circumstances arising as a result of events beyond the Director's or Beneficiary's control,
(2) such circumstances would result in severe financial hardship to the individual if early withdrawal is not permitted, and (3) any other requirements established under the Code and regulations
promulgated thereunder, applying the standards established under Section 457 of the Code and the regulations promulgated thereunder, are satisfied. A severe financial hardship exists only when all
other reasonably available financial 

4

 

resources
have been exhausted, including but not limited to (1) reimbursement or compensation by insurance or otherwise, (2) liquidation of the Director's assets, to the extent that liquidation of
such assets would not itself cause severe financial hardship, or (3) cessation of deferrals under the Plan. Examples of what are not considered to be unforeseeable emergencies include the need to send
a Director's child to college or the desire to purchase a home. 

        The
Committee shall have sole discretion to determine whether to approve any hardship withdrawal, which amount will be limited to the amount necessary to meet the emergency. The
Committee's decision is final and binding on all interested parties. A Director who is then serving as a member of the Committee shall not vote on whether or not he or she is eligible for such a
hardship withdrawal. 

Section 8.    Designation of Beneficiaries.

        The
Director shall, in accordance with procedures established by the Committee, (1) designate one or more Beneficiaries hereunder, and (2) shall have the right thereafter to change such
designation. In the case of a Director's death, payment due under this Plan shall be made to the designated Beneficiary or Beneficiaries or, in the absence of such designation, by will or the laws of
descent and distribution in the Director's state of residence at the time of his or her death. 

Section 9.    Change in Control.

        9.1   Discretion
to Accelerate.    In the event of a proposed change in control of Agilent, as defined below, the Committee shall have
complete authority and discretion, but no obligation, to accelerate payments of all Directors, both terminated and active Directors. 

        9.2   Proposed
Change in Control.    A "proposed change in control" shall mean (1) a tender offer by any person or entity, other than
Agilent or an Agilent subsidiary, to acquire securities representing 40 percent or more of the voting power of Agilent or (2) the submission to Agilent's shareholders for approval of a transaction
involving the sale of all or substantially all of the assets of Agilent or a merger of Agilent with or into another corporation. 

        9.3   Request
for Negotiation.    The Committee may also ask the Board of Directors to negotiate, as part of any agreement involving the
sale or merger of Agilent, or a sale of substantially all of Agilent's assets or a similar transaction, terms providing for protection of Directors and their interests in the Plan. 

Section 10.    Limitation on Assignments.

        Benefits
under this Plan are not subject to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, attachment or garnishment by creditors of the Director or the
Director's Beneficiary and any attempt to do so shall be void. 

Section 11.    Administration.

        11.1     Administration
by Committee.    The Committee shall administer the Plan. Notwithstanding any provision of the Plan
to the contrary, no member of the Committee shall be entitled to vote on any matter which would create a significant risk that such member could be 

5

 

treated
as being in constructive receipt of some or all of his or her Deferral Account. The Committee shall have the sole authority to interpret the Plan, to establish and revise rules and regulations
relating to the Plan and to make any other determinations that it believes necessary or advisable for the administration of the Plan. Decisions and determinations by the Committee shall be final and
binding upon all parties, including shareholders, Directors, Beneficiaries and other employees. The Committee may delegate its administrative responsibilities, as it deems appropriate. 

        11.2     Books
and Records.    Books and records maintained for the purpose of the Plan shall be maintained by the officers
and employees of Agilent at its expense and subject to supervision and control of the Committee. 

Section 12.    No Funding Obligation.

        Agilent
is under no obligation to transfer amounts credited to the Director's Deferral Account to any trust or escrow account, and Agilent is under no obligation to secure any amount
credited to a Director's Deferral Account by any specific assets of Agilent or any other asset in which Agilent has an interest. This Plan shall not be construed to require Agilent to fund any of the
benefits provided hereunder nor to establish a trust for such purpose. Agilent may make such arrangements as it desires to provide for the payment of benefits, including, but not limited to, the
establishment of a grantor trust or such other equivalent arrangements as Agilent may decide. No such arrangement shall cause the Plan to be a funded plan within the meaning of Title I of ERISA, nor
shall any such arrangement change the nature of the obligation of Agilent nor the rights of the Directors under the Plan as provided in this document. Neither the Director nor his or her estate shall
have any rights against Agilent with respect to any portion of the Deferral Account except as a general unsecured creditor. No Director has an interest in his or her Deferral Account until the
Director actually receives the deferred payment; provided, that Agilent may, in its sole discretion and in accordance with applicable law, make arrangements to allow a Director to direct the voting of
Shares deemed to be credited to the Director's Deferral Account. 

Section 13.    Amendment and Termination of the Plan.

        Agilent,
by action of the Committee, in its sole discretion may suspend or terminate the Plan or revise or amend it in any respect whatsoever; provided, however, that amounts already
credited to Deferral Accounts will continue to be owed to the Directors or Beneficiaries and continue to be a liability of Agilent. Any amendment or termination of the Plan will not affect the
entitlement of any Director or the Beneficiary of a Director who terminates service before the amendment or termination. All benefits to which any Director or Beneficiary may be entitled shall be
determined under the Plan as in effect at the time the Director terminates service and shall not be affected by any subsequent change in the provisions of the Plan; provided, however, that Agilent
reserves the right to change the basis of return on investment of the Deferral Account with respect to any Director or Beneficiary. Directors or Beneficiaries will be given notice prior to the
discontinuance of the Plan or reduction of any benefits provided by the Plan. Notwithstanding any other provision of the Plan, Agilent may without Director or Beneficiary consent amend the Plan or
change the Plan's administrative rules and procedures to comply with Section 409A of the Code. 

6

 

Section 14.    Adjustment on Changes in Capitalization.

        If
any change, such as a stock split or dividend, is made in Agilent's capitalization, and the change results in an increase or decrease in the number of issued shares of common stock
without receipt of consideration by Agilent, an appropriate adjustment shall be made in the corresponding number of Shares payable under the Plan. 

Section 15.    Tax Withholding.

        If
Agilent concludes that Tax is owing with respect to any deferral of income or payment hereunder, Agilent shall withhold such amounts from any payments due the Director, or otherwise
make appropriate arrangements with the Director or his or her Beneficiary for satisfaction of such obligation. 

Section 16.    Choice of Law.

        This
Plan shall be interpreted and construed in accordance with the laws of the State of California, excluding the conflicts of laws provisions thereof, and is not subject to ERISA. 

Section 17.    Notice.

        Any
written notice to Agilent required by any of the provisions of this Plan shall be addressed to the chief personnel officer of Agilent or his or her delegate and shall become
effective when it is received. 

Section 18.    No Rights to Continued Service.

        Nothing
in the Plan nor any action of Agilent pursuant to the Plan, shall be deemed to give any person the right to continued service as a member of the Board of Directors of Agilent or
affect the right of the Board of Directors of Agilent and/or Agilent's shareholders to remove an individual from the Agilent Board of Directors in accordance with the General Corporation Law of the
State of Delaware, Agilent's governing documents, including Agilent's Articles of Incorporation and Bylaws, and any other applicable law. 

Section 19.    Severability of Provisions.

        If
any particular provision of this Plan is found to be invalid or unenforceable, such provision shall not affect any other provisions of the Plan, but the Plan shall be construed in all
respects as if such invalid provision had been omitted. 

Section 20.    Code Section 162(m).

        Notwithstanding
any other provision of the Plan, except in the event of an acceleration of payment in connection with a proposed change in control under Section 9, the maximum amount
that is not "performance-based" (as defined in Section 162(m)(4)(C) of the Code) which may be paid to a Covered Officer under the Plan in any fiscal year shall not exceed one million dollars 

7

 

($1,000,000)
less the amount of other compensation paid to the Director by the Company in such fiscal year that is not 'performance-based' (as defined in Section 162(m)(4)(C) of the Code), which
amounts shall be reasonably determined by the Committee at the time of the proposed payout. Any amount which is not paid to the Covered Officer in a fiscal year as a result of this limitation shall be
paid to the Covered Officer in the next fiscal year, subject to compliance with the foregoing limitation, or if sooner, as soon as reasonably practicable following the Director's ceasing to be a
Covered Officer. 

Section 21.    Definitions.

        21.1     Agilent
means Agilent Technologies, Inc., a Delaware corporation, and any business entity within the Agilent consolidated
group. 

        21.2     Beneficiary
means the person or persons designated by a Director pursuant to Section 8, in accordance with and accepted by
Agilent, to receive any amounts payable under the Plan in the event of the Director's death. 

        21.3     Code
means the Internal Revenue Code of 1986, as amended from time to time. 

        21.4     Committee
means the Compensation Committee of the Board of Directors of Agilent or its delegate. 

        21.5     Covered
Officer shall have the same meaning as "covered employee" does under Section 162(m) of the Code. 

        21.6     Deferral
Account means the account balance of a Director in the Plan created from Deferred Amounts. 

        21.7     Deferred
Amount means the amount the Director elects to have deferred from his or her annual cash retainer and committee
fees. 

        21.8     Deferred
Share Credits means amounts credited to a Director under the Plan through an automatic grant pursuant to Section
3.4, as provided under the Director Stock Plan. 

        21.9     Director
means an individual who is serving as a member of Agilent's Board of Directors and who is not then an employee of
Agilent or any of Agilent's affiliates. 

        21.10     ERISA
means the Employee Retirement Income Security Act of 1974, as amended from time to time. 

        21.11     Payout
Commencement Date means the date on which the payout to a Director of amounts credited to his or her Deferral Account
first commences. 

        21.12     Plan
means the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors. 

        21.13     Shares
mean shares of the common stock of Agilent Technologies, Inc. 

8

 

        21.14     Tax
or (Taxes) means any federal, state, local, or any other governmental income tax, employment tax, payroll tax, excise
tax, or any other tax or assessment owing with respect to amounts deferred, any Earnings thereon, and any payments made to Directors or Beneficiaries under the Plan. 

        21.15     Termination
Date means the date on which the Director ceases to be a Director of Agilent. 

        21.16     Termination
Year means the calendar year within which a Director's Termination Date falls. 

9

QuickLinks

Exhibit 10.59

AGILENT TECHNOLOGIES, INC. 2005 DEFERRED COMPENSATION PLAN FOR NON-EMPLOYEE DIRECTORS (Amended and Restated Effective as of November 1, 2005)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}]]